Quantum-Si’s (QSI) Buy Rating Reiterated at HC Wainwright

Quantum-Si (NASDAQ:QSI)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Tuesday, MarketBeat Ratings reports. They presently have a $4.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 307.33% from the stock’s current price.

A number of other research firms also recently issued reports on QSI. Weiss Ratings raised shares of Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday. Wall Street Zen raised shares of Quantum-Si from a “sell” rating to a “hold” rating in a report on Saturday, September 12th. Finally, Alliance Global Partners reissued a “buy” rating on shares of Quantum-Si in a report on Friday, August 14th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $2.50.

Quantum-Si Stock Performance

QSI traded up $0.19 on Tuesday, reaching $0.98. The company had a trading volume of 10,462,118 shares, compared to its average volume of 4,349,560. Quantum-Si has a fifty-two week low of $0.69 and a fifty-two week high of $3.10. The stock has a market cap of $214.94 million, a P/E ratio of -2.15 and a beta of 3.25. The company’s fifty day moving average is $0.77 and its 200 day moving average is $0.87.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, meeting analysts’ consensus estimates of ($0.11). Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. The business had revenue of $0.34 million for the quarter, compared to analyst estimates of $0.30 million. On average, sell-side analysts expect that Quantum-Si will post -0.47 EPS for the current year.

Institutional Trading of Quantum-Si

A number of institutional investors have recently bought and sold shares of QSI. Hollencrest Capital Management lifted its stake in Quantum-Si by 301.1% in the 1st quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock valued at $31,000 after purchasing an additional 30,111 shares during the last quarter. IPG Investment Advisors LLC bought a new position in Quantum-Si in the 2nd quarter valued at approximately $27,000. Corient Private Wealth LP bought a new position in Quantum-Si in the 2nd quarter valued at approximately $34,000. Green Alpha Advisors LLC bought a new position in Quantum-Si in the 2nd quarter valued at approximately $41,000. Finally, WINTON GROUP Ltd bought a new position in Quantum-Si in the 2nd quarter valued at approximately $67,000. Institutional investors own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.

Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.